The NHS's new strategy for genomics: Five key takeaways

We look at the new ‘Accelerating genomic medicine in the NHS’ report and what it means for healthcare professionals

Achromatopsia gene therapy partially restores children’s colour vision

A new gene therapy for achromatopsia has partially restored colour vision in two children, according to new research

Reducing stroke risk with a genetic test

NHS Tayside introduces the UK's first routine genetic test for stroke patients, estimated to bring improved outcomes to thousands of patients each year
Genomics in Primary Care

Bringing whole genome sequencing to primary care

We explore how first-contact care and genomic testing could align, and the pivotal part this combination could play in the future

Mendel: Influence and inheritance

We celebrate the father of genetics’ 200th birthday and explore the ways his influence still extends through to us today

PPP rare diseases report: Five things we learned

We round up the key genomics points from the latest Public Policy Projects report

Detecting cancer predisposition: Finding the balance

This week, we weigh up the potential advantages and challenges of wider genomic testing for identifying cancer

The Genomics Conversation: What matters to patients

The GEP recently met with patients and their relatives to talk about their experiences of genomic testing and the key insights they want healthcare professionals to know
Adult holding baby's hand in hospital

NICE approves world-first MLD therapy

We explore a new gene therapy for a rare, fatal condition that affects young children
Mother holding baby's hand

NHS launches sight-saving NIPT test

A new genomic test can identify babies at risk of a rare form of eye cancer with almost 100% accuracy

Rapid genomic test helps prevent newborn hearing loss

We look at how rapid pharmacogenomic testing is helping save the hearing – and lives – of newborn babies

NHS launches sequencing pilot for glioblastoma

A new programme is bringing genomics-based personalised treatment to brain cancer patients for the first time